Citius Pharmaceuticals
Presence
Citius Pharmaceuticals is a company listed under the stock ticker CTXR (US).
Executives
View the org chart displaying its 18 main executives
Most searched biographies at Citius Pharmaceuticals
- Leonard Mazur, Chairman of the Board and Chief Executive Officer
- Myron Holubiak, Vice Chairman of the Board
- Carol Webb, Director
Create your alert
to follow the executive moves at Citius Pharmaceuticals.
Pharmaceuticals
Citius Pharmaceuticals has 1,861 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Citius Pharmaceuticals
- Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma
- Citius Pharmaceuticals to Present at the LD Micro Invitational XIV Investor Conference
- Citius Pharmaceuticals Announces FDA Acceptance of the BLA Resubmission of LYMPHIR™ (Denileukin Diftitox) for the Treatment of Adults with Relapsed or Refractory Cutaneous T-Cell Lymphoma
- Citius Pharmaceuticals, Inc. Secures $2.4 million through New Jersey Economic Development Program
- Citius Pharmaceuticals Announces Filing of Form S-3 Shelf Registration Statement to Replace Expiring Prior Shelf Registration
- Citius Pharmaceuticals to Participate in Upcoming BIO CEO and Sidoti Investor Conferences
- Citius Pharmaceuticals Resubmits the Biologics License Application of LYMPHIR™ (Denileukin Diftitox) for the Treatment of Adults with Relapsed or Refractory Cutaneous T-Cell Lymphoma
- Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2024 Financial Results and Provides Business Update
- Citius Pharmaceuticals Announces Nomination of Pharmaceutical Executive Robert J. Smith to its Board of Directors
- Citius Pharmaceuticals, Inc. - Citius Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Trial of its Mino-Lok® Therapeutic to Salvage Catheters
- View more press releases Close
Social media about Citius Pharmaceuticals
- Citius Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Citius Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Leonard Mazur 
Call Citius Pharmaceuticals at +1 617...
